Science News & Science Current Events
 

Drugs Current Events | Drugs News | 9

Sort By: Page Views | Date
MRI drug may improve cancer-killing ability of chemotherapy, study says
A contrast agent currently used in magnetic resonance imaging (MRI), called mangafodipir, may increase the cancer-killing ability of some chemotherapy drugs while protecting normal cells.   view more (2006-02-15)

New Oxford Spin-out to Improve on Drug Delivery
Oxford University's latest spin-out company is the drug delivery and glycoprotein specialist Glycoform Ltd, which uses expertise in identifying novel carbohydrate - cell surface receptor- binding properties to develop unique drug targeting systems. The company is developing a novel technology known... view more (2002-12-23)

Slipping past the blood brain barrier: Research shows potential treatment for brain cancer
A compound that kills cancer can sneak past the blood brain barrier, which protects the brain from foreign substances, to do its work in fighting a particularly invasive brain cancer.   view more (2005-08-23)

Swimming with dolphins can alleviate depression
Swimming with dolphins is an effective treatment for mild to moderate depression, say researchers in this week's BMJ.   view more (2005-11-28)

Lower IQ found in children of women who took epilepsy drug
Children of women who took the epilepsy drug valproate during pregnancy appear to be at a greater risk for lower IQ.   view more (2007-05-04)

New target for anti-flu drug development
cientists at Cure Lab, Inc., a biotechnology company based in Canton, Massachusetts, in collaboration with researchers at Boston University and Harvard Medical School have discovered a potential new target for the development of anti-influenza (flu) drugs, including those that may be effective... view more (2007-08-16)

Measures needed to reduce bloodborne infections in Irish prisons
There is an urgent need for increased infection control and harm reduction measures to reduce the transmission of hepatitis B and C viruses, and HIV in Irish prisons, concludes a study in this week's BMJ.   view more (2001-11-20)

10 per cent of human genome is target for new drugs
Around 10 per cent of the human genome can be targeted for the development of new drugs, according to top pharmaceutical industry scientists speaking at the BA Festival of Science at the University of Glasgow today [3rd September 2001]. Speaking at the From genes and cells to healthcare forum... view more (2001-08-30)

Vaccine royalties to Institute for Animal Health pass £1M mark
Collaborative research into the parasitic disease coccidiosis in chickens has so far brought over £1m in royalties to the Institute for Animal Health (IAH) from sales of Paracox vaccines. The Paracox vaccines have now become the biggest selling live attenuated vaccines ever against protozoan... view more (2003-06-17)

£2 Million of Yeast Could Triple Available Drug Treatments
Researchers are to employ the humble yeast cell to greatly increase – perhaps even triple - the number of drug treatments for common diseases such as allergies, asthma, obesity, type 2 diabetes, schizophrenia, heart disease, osteoporosis and cancer.   view more (2003-02-05)

Promising new drug targets identified for Huntington's disease
Research funded by the Wellcome Trust has provided a number of promising new drug targets for Huntington's disease, a neurodegenerative disease. Scientists at the University of Cambridge have identified a number of candidate drugs to investigate further which encourage cells to "eat" the... view more (2008-03-24)

ß blockers may affect airways function in elderly patients
Topical ß blockers are the most commonly prescribed drugs for glaucoma in the United Kingdom, yet a study in this week’s BMJ finds that they are associated with excess risk of airways obstruction in elderly patients.   view more (2002-12-11)

Inherited genes linked to toxicity of leukemia therapy
Investigators at St. Jude Children's Research Hospital have discovered inherited variations in certain genes that make children with acute lymphoblastic leukemia (ALL) susceptible to the toxic side effects caused by chemotherapy medications.   view more (2007-05-14)

Gold nanoparticles could improve antisense cancer drugs
In the fight against cancer, antisense drugs, which prevent genes from producing harmful proteins such as those that cause cancer, have the promise to be more effective than conventional drugs, but the pace of development of these new drugs has been slow.   view more (2006-05-19)

College freshmen: pain killers and stimulants less risky than cocaine; more risky than marijuana
First year college students believe that occasional nonmedical use of prescription pain killers and stimulants is less risky than cocaine, but more risky than marijuana or consuming five or more alcoholic beverages every weekend.   view more (2008-09-03)

Allergy battle could be won in five years, says scientist
Researchers, working with colleagues at St George's, University of London, are developing drugs designed to stop allergens from entering the body, so rendering them harmless.   view more (2006-07-13)

Nano-particles Effective in Killing Cancer with One-Two Punch of Chemotherapeutics
Research studies, based at the University of Pennsylvania, demonstrate that biodegradable nano-particles containing two potent cancer-fighting drugs are effective in killing human breast tumors.   view more (2006-04-11)

Understanding the Noxious cause of Lou Gehrig's disease
There is no known cure for amyotrophic lateral sclerosis (ALS), often known as Lou Gehrig disease and motor neuron disease.   view more (2007-09-14)

Stealth particles to target tumors
Stealth nano particles may some day target tumor cells and deliver medication to specific body locations, according to Penn State chemical engineers.   view more (2005-09-01)

UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells
Researchers at UCLA have successfully manipulated nanomaterials to create a new drug-delivery system that promises to solve the challenge of the poor water solubility of today's most promising anticancer drugs and thereby increase their effectiveness.   view more (2007-06-08)

Cost-effectiveness of drugs may vary across borders
A study published in the journal Value in Health reviews variations in estimates of cost-effectiveness of pharmaceuticals from country to country. Data showed that the results seen in one country are not necessarily applicable in another and that decision makers need to interpret data from other... view more (2005-04-14)

Benefits Of Anti-Clotting Drug Class For People With Acute Coronary Syndromes - But For Men Only? (p 189)
Results of a meta-analysis in this week's issue of THE LANCET lend further support to the benefits of the anti-clotting drugs glycoprotein IIb/IIIa inhibitors for the treatment of patients with acute coronary syndromes. However, an unexpected finding of the study suggests that men might be more... view more (2002-01-17)

Harnessing Microbes to Kill Cancer
An ingenious new way to attack cancer tumours is being developed by medical researchers from Nottingham as part of an EU consortium, the Society for General Microbiology's Spring Meeting in Edinburgh heard today, Tuesday 8 April 2003. The problem with powerful anti-cancer drugs is that they kill... view more (2003-04-02)

Researchers create mouse lacking key inflammation gene
In a paper published yesterday in The Proceedings of the National Academy of Science (PNAS), researchers from Boston University School of Dental Medicine generated a mouse model exhibiting reduced inflammation.   view more (2006-09-07)

Fresh Hopes For Treatment Of Malaria In Africa (p 1218)
Despite the large number of deaths caused worldwide by AIDS, tuberculosis, and diarrhoeal diseases such as cholera, the biggest infectious-disease killer is still malaria, especially in Africa. Efforts to eradicate the carrier of malaria, a mosquito, have been only partly successful. The standard... view more (2001-10-10)

Sort By: Page Views | Date
© 2008 BrightSurf.com